MOLLY HAWLEY: Open Payments
NPI 1316179286 · LEXINGTON, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$436 in 26 payments from 14 companies in 2025. Trend: 2023 $601 · 2024 $674 · 2025 $436
Food & beverage: $436
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 4 | $65 |
| Novo Nordisk Inc | 4 | $62 |
| GlaxoSmithKline, LLC. | 3 | $48 |
| Novartis Pharmaceuticals Corporation | 2 | $41 |
| Medtronic, Inc. | 2 | $34 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $33 |
| Amgen Inc. | 2 | $32 |
| Insulet Corporation | 1 | $24 |
| ABBVIE INC. | 1 | $20 |
| Inspire Medical Systems, Inc. | 1 | $16 |
Products named: JARDIANCE, TRELEGY ELLIPTA, MOUNJARO, LEQVIO, MINIMED 780G, Ozempic, EVENITY, Omnipod.
Industry payments across KY — which companies pay providers there.
